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Sexual Dimorphism of Myointimal Proliferation
After Balloon Injury of Rat Carotid Artery is
Estrogen Dependent
Basic Fibroblast Growth Factor has Potent
Selective Effects on Collagen Gene Expression
by Human Vascular Smooth Muscle Cells
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Basic fibroblast growth factor (bFGF) is a smooth muscle cell (SMC) mito-
gen known to playa role in the early response of the vessel wall to balloon
injury. During this initial stage, remodeling of the extracellular matrix (ECM),
including collagen. is necessary for cell proliferation, migration and lesion
expansion. We therefore determined the effect of bFGF on fibrillar collagen
gene expression by human vascular SMCs.
SMCs, cultivated from internal mammary artery, were serum-deprived and
incubated with bFGF (50 nglml) or vehicle. Collagen synthesis rate was de-
termined by labeling cultures with [3H]proline, separating proteins byelec-
trophoresis, and visualizing and quantifying bands by fluorography and laser
densitometry, respectively. This revealed a significant, net decrease in col-
lagen synthesis induced by bFGF. To determine the mechanism of this re-
sponse, the effect of bFGF on collagen mRNA was determined by North-
ern blot analysis using probes specific for a-chains of collagen types I, III,
and V, accounting for the major and minor fibrillar collagens found in human
atherosclerotic plaque. Cell proliferation was assessed by probing for his-
tone 3.2. Despite a consistent increase in SMC proliferation. bFGF reduced
expression of 0'1 (I) collagen mRNA by upto 90%. In contrast, bFGF increased
expression of 0'1(111) and a2(V) collagen mRNA by approximately 20%. Be-
cause type III and V collagen fibers are finer than type I, the divergent results
may reflect a shift to a less mature collagen lattice induced by bFGF.
Conclusion: Total fibrillar collagen synthesis by human SMCs is reduced
by bFGF, due to a potent selective inhibition of type I collagen expression.
This effect of bFGF on the ECM may be a prerequisite for SMC accumulation
and lesion formation following balloon angioplasty.
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Atherosclerotic vascular disease progresses more slowly in females with
functional ovaries than in males. Balloon injury of the rodent carotid artery is
widely used as a model for the early injury phase of atherosclerosis. The cur-
rent study tested whether female Sprague-Dawley rats (SD) have a reduced
(compared to males) vascular growth response to balloon injury and whether
this response is estrogen dependent. 10 wk old d' and ~ SD rats were ei-
ther gonadectomized or studied intact. Gonadectomized rats of both sexes
were implanted with (1) 15 mm (empty), (2) 10 mm (filled with 17-,8 estradiol
[E]) or (3) 15 mm (filled with testosterone [Tl) silastic capsules 3 days before
balloon injury of the carotid artery. Two wks later, rats were perfused with
10% formalin at 120 mmHg and carotid arteries were fixed and subjected to
morphometric analysis. Intima/media ratios (I/M%) expressed as degree of
myointimal proliferative response to vascular injury were (means ± SEM):
ducible. Rat aortic SMC were plated at a 1:3 split ratio in 1% fetal bovine
serum (FBS), and made quiescent 24 hr later by changing the medium to 1%
control process serum replacement II. Cells were stimulated with PDGF (2
ng/ml), and at the same time, oligonucleotides were added. Cell proliferation
was determined by measuring 3H-Thymidine uptake at 18-22 hr. To compare
the specificity olthe antiproliferative effects. 20 J.LM of AS c-myb and several
control oligos were used. These included (Batch A): 18-mer sense (5) c-myb.
19-mer mouse antisense and four-base mismatch AS to Il-l,8, and 18- and
16-mer human AS to CML. To determine the reproducibility of the AS ef-
fect, the same 18-mer AS c-myb and scrambled (Sc) lS-mer from another
source (B) were used under exactly the same conditions. To further evaluate
the reproducibility of the AS effect, two different preparations (Batch C) of
the same 18-mer AS and S c-myb from the initial manufacturer were tested
under exactly the same culture conditions.
Conclusions: This study shows: 1) that antisense oligonucleotides pro-
duce a non-specific in-vitro antiproliferative effect and 2) the in-vitro results
may vary with respect to source and batches of oligonucleotides. The lack of
consistency in results raises significant questions about clinical therapeutic
potential.
1968-281
In Vivo Incorporation Kinetics of 35S Labelled
Antisense c-myc Oligonucleotides in Rabbits
Carotid Arteries
In Vitro Antiproliferative Effect of Antisense
Oligonucleotides: Are the Effects Specific and
Reproducible?
Genetic Modification of Atherosclerotic Arteries
Following Balloon Angioplasty
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Antisense oligonucleotides oligonucleotides complementary to c-myc
mRNA inhibit smooth muscle cell proliferation in vitro and may reduce the
proliferative response to vascular injury in vivo following balloon angioplasty.
The purpose of this study was to evaluate the in vivo incorporation kinetics
of 35S labelled phosphorothioate antisense c-myc oligonucleotides by as-
sessing the effect of transfection time, of lipofectin or Iipofectamin on tis-
sue penetration and retention following transfection in the carotid artery. A
total of 117 New Zealand white rabbit carotid arteries were transfected with
80 J.LM of c-myc antisense oligonucleotide in a 1 cm portion either alone
(n = 37) or in combination with lipofectin (100 /Lg/ml or 500 /Lg/ml) (n =
50) or lipofectamin (100 /Lg/ml or 500 /Lg/ml) (n = 30) for periods of either
15,30,60, 120 or 240 minutes. Radiolabelled oligonucleotide incorporation
level was evaluated by automated scintillation counting and tissue localisa-
tion by dot counting following radiographic emulsion exposure of histolog-
ical sections. Retention evaluation was performed at 24, 48 and 72 hours
post-transfection. A high correlation factor (r2 = 0.96) was obtained between
the two evaluation methods. Maximal incorporation was seen after 15 min
exposure (7.84% ± 1.59%, P < 0.05 vs other groups). Maximal radioactivity
retained was found at 24 hours (0.743% incorporation ± 0.096%), decreas-
ing rapidly thereafter (0.57% at 48 hours and 0.247% at 72 hours, p < 0.05).
Efficiency of transfection was not increased by lipofectin or lipofectamin. la-
belled oligonucleotide were located mainly in the media (3.85E + 07 dots ±
5.85E + 06 dots) and significantly less in the adventia (7.55E + 06 dots ±
1.84E + 06 dots). Conclusions: l-In vivo vascular transfection of phospho-
rothioate oligonucleotides, without specific vectors, results in good medial
tissue penetration, with however a low retention level after 24 hours. 2- This
transfer modality does not appear to be enhaced with the use of Iiposomes.
Genetic modification of the vessel wall by catheter-based techniques of-
fers great potential in the treatment of atherosclerotic vascular disease. This
study was therefore undertaken to characterize the response of atheroscle-
rotic vessels exposed to adenoviral vectors following balloon angioplasty.
Atherosclerotic lesions were created in iliac arteries of NZW rabbits by en-
dothelial denudation. After 4-6 weeks on a 1.5% cholesterol diet, balloon
angioplasty was performed at the site of maximal stenosis detected by iliac
angiography. Recombinant adenovirus encoding a nuclear-localizing variant
of E. coli ,8-galactosidase (,8Gal) was then delivered to the vessels by 1 of
4 techniques: a double balloon catheter (n = 7), a Hydrogel-coated balloon
catheter (n = 3), a perforated balloon infusion catheter (n = 3), or a Dispatch
catheter (n = 4). Four days after infection, sections of the modified vessels
were harvested and stained with X-gal solution. Eosin-counterstained sec-
tions were examined forthe presence and location of ,8Gal activity. Success-
ful gene transfer was observed in all sections displaying evidence of balloon-
induced barotrauma, manifested primarily by arterial dissection, regardless
of the device used. Genetically modified cells were located in pockets within
the intima, media, and adventitia bordering dissection planes, or in areas ad-
jacent to defects in the internal elastic membrane. To a lesser degree, cells
expressing ,8Gal were found in peri luminal regions of the intact intima. Ex-
tensive transmural or circumferential diffusion of the vector was not seen.
In conclusion, gene transfer to an atherosclerotic vessel subjected to bal-
loon angioplasty is feasible with recombinant adenovirus vectors and cur-
rently available delivery catheters. The regions of the vessel wall which ex-
press the foreign protein are those which contribute to the proliferative cel-
lular response which characterizes post-angioplasty restenosis.
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The involvement of proto-oncogenes in cell proliferation is well documented.
One of these, the oncogene c-myb is a DNA-binding protein that regulates
cell growth and differentiation. In-vitro studies have shown marked inhibi-
tion of smooth muscle cell (SMC) proliferation using antisense (AS) c-myb
oligonucleotides. The purpose of this study was to determine whether the
in-vitro antiproliferative effect of AS oligonucleotides is specific and repro-
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